Latest filings (excl ownership)
NT 10-Q
Notice of late quarterly filing
17 Jan 24
10-K
2023 FY
Annual report
16 Jan 24
8-K
Entry into a Material Definitive Agreement
13 Dec 23
NT 10-K
Notice of late annual filing
29 Nov 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7 Nov 23
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
16 Oct 23
10-Q
2023 Q3
Quarterly report
13 Sep 23
8-K
Entry into a Material Definitive Agreement
8 Sep 23
8-K
Departure of Directors or Certain Officers
11 Aug 23
NT 10-Q
Notice of late quarterly filing
18 Jul 23
10-Q
2023 Q2
Quarterly report
30 May 23
8-K
Entry into a Material Definitive Agreement
21 Apr 23
D
$280.00 k in debt / options, sold $186.67 k, 2 investors
21 Apr 23
NT 10-Q
Notice of late quarterly filing
14 Apr 23
10-Q
2023 Q1
Quarterly report
17 Jan 23
D
$300.00 k in debt / options, sold $300.00 k, 3 investors
27 Dec 22
10-K
2022 FY
Annual report
15 Dec 22
8-K
Entry into a Material Definitive Agreement
12 Dec 22
8-K
Amendments to Articles of Incorporation or Bylaws
30 Nov 22
NT 10-K
Notice of late annual filing
29 Nov 22
8-K
Departure of Directors or Certain Officers
17 Nov 22
8-K
Completion of Acquisition or Disposition of Assets
14 Nov 22
8-K
Departure of Directors or Certain Officers
25 Oct 22
8-K
Innovation1 Biotech Appoints Frederick E. Pierce, II to its
15 Sep 22
8-K
Innovation1 Biotech Appoints Chief Scientific Officer
15 Aug 22
10-Q
2022 Q3
Quarterly report
14 Jul 22
8-K
Regulation FD Disclosure
27 Apr 22
8-K
Departure of Directors or Certain Officers
21 Apr 22
8-K
Regulation FD Disclosure
18 Apr 22
10-Q
2022 Q2
Quarterly report
15 Apr 22
NT 10-Q
Notice of late quarterly filing
15 Apr 22
8-K
Departure of Directors or Certain Officers
7 Apr 22
8-K
Amendments to Articles of Incorporation or Bylaws
6 Apr 22
424B3
Prospectus supplement
10 Mar 22
EFFECT
Notice of effectiveness
10 Mar 22
S-1/A
IPO registration (amended)
8 Mar 22
CORRESP
Correspondence with SEC
8 Mar 22
UPLOAD
Letter from SEC
18 Feb 22
S-1
IPO registration
15 Feb 22
8-K
Departure of Directors or Certain Officers
10 Feb 22
Latest ownership filings